Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress
Go back to Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress| (NASDAQ: COAG) | Delayed: 44.41 +0.04 (0.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.37 | 52 Week High | $ | |||
| Open | $43.40 | 52 Week Low | $ | |||
| Day High | $45.49 | P/E | N/A | |||
| Day Low | $43.29 | EPS | $ | |||
| Volume | 302,046 | |||||
